Find Therapeutics secured CA$10 million in funding to continue advancing tasronetide, its treatment to restore damaged myelin ...

MS has a way of making everything feel interconnected, writes columnist Desiree Lama, and that includes her relationship with ...

A group of international experts is proposing a first-of-its-kind framework to prevent multiple sclerosis (MS) from ...

People with MS who have mild disability still experience disease-related difficulties at work, a new study found, calling for ...

Evogene and Unravel Biosciences are collaborating to use AI to speed the development of therapies that promote myelin sheath ...

Inflammatory gut bacteria that carry proteins structurally similar to myelin may trigger the development and progression of ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...

Frustrated by past New Year's resolutions, columnist Desiree Lama is setting intentions to help redefine what progress with ...

England's NICE is recommending natalizumab, sold as Tysabri and Tyruko, as an NHS-covered treatment option for people with ...

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.